Properties of rat bone inorganic pyrophosphatase studied by means of  32 P-radioassay.
D000818:Animals; D001205:Ascorbic Acid / Q000494:pharmacology; D001464:Barium / Q000494:pharmacology; D001842:Bone and Bones / Q000201:enzymology*; D002729:Chloromercuribenzoates / Q000494:pharmacology; D003035:Cobalt / Q000494:pharmacology; D003545:Cysteine / Q000494:pharmacology; D004229:Dithiothreitol / Q000494:pharmacology; D004492:Edetic Acid / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D007461:Iodoacetates / Q000494:pharmacology; D007501:Iron / Q000494:pharmacology; D008274:Magnesium / Q000494:pharmacology; D008345:Manganese / Q000494:pharmacology; D008628:Mercury / Q000494:pharmacology; D010759:Phosphorus Isotopes; D011755:Pyrophosphatases / Q000032:analysis* / Q000037:antagonists & inhibitors / Q000097:blood; D051381:Rats; D013977:Tibia / Q000201:enzymology; D015032:Zinc / Q000494:pharmacology
D002729:Chloromercuribenzoates; D007461:Iodoacetates; D010759:Phosphorus Isotopes; D001464:Barium; D003035:Cobalt; D008345:Manganese; D004492:Edetic Acid; D007501:Iron; D011755:Pyrophosphatases; D008628:Mercury; D008274:Magnesium; D015032:Zinc; D003545:Cysteine; D001205:Ascorbic Acid; D004229:Dithiothreitol